Home / Companies / Shanghai Allist Pharmaceuticals Co., Ltd. / 13 May 2026
Shanghai Allist Pharmaceuticals Co., Ltd.: meeting of 13 May 2026
Votes reported on Form N-PX, item by item
26 Form N-PX filers reported votes at the Shanghai Allist Pharmaceuticals Co., Ltd. meeting of 13 May 2026. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.
8 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
43 vote records from 25 filers. 0 of the 25 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
161 vote records from 26 filers. 0 of the 26 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
86 vote records from 26 filers. 0 of the 26 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
92 vote records from 26 filers. 0 of the 26 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
6 vote records from 5 filers. 0 of the 5 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | No report | For |
| BlackRock and iShares | For | For |
| Fidelity | No report | For |
| Dimensional | No report | For |
| Franklin Templeton | No report | For |
| Charles Schwab | No report | For |
| Nuveen and TIAA | No report | For |
| John Hancock and Manulife | No report | For |
| Goldman Sachs | No report | For |
| Jackson National funds | No report | For |
| Northern Trust and FlexShares | No report | For |
| Voya | No report | For |
| Pacific Life funds | No report | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Shanghai Allist Pharmaceuticals Co., Ltd. meeting?
26 Form N-PX filers reported votes at the meeting of 13 May 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shanghai Allist Pharmaceuticals Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Shanghai Allist Pharmaceuticals Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shanghai Allist Pharmaceuticals Co., Ltd. with a meeting date within three days of 13 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.